Clinical Research Directory
Browse clinical research sites, groups, and studies.
Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease
Sponsor: University Hospital, Toulouse
Summary
Since our previous study has shown that some personality dimensions were associated with Quality of Life (QoL) amelioration after Deep Brain Stimulation (DBS) in Parkinson's disease (PD), the investigators aim to evaluate the impact of personality dimensions on therapeutic response after another second-line treatment: the continuous subcutaneous apomorphine infusion (CSAI). Moreover, the investigators would like to evaluate the potential evolution of personality dimensions through CSAI. The investigators also aim to evaluate other bio-psycho-social factors (representations of the disease, ways of copying and social support) influence on QoL amelioration after DBS.
Official title: Could Psycho-bio-social Context and Personality be a Predictive Factor of Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease Patients? - PERSO-PERF Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2024-02-15
Completion Date
2026-04-01
Last Updated
2024-08-29
Healthy Volunteers
No
Conditions
Interventions
Continuous subcutaneous apomorphine infusion (CSAI)
the CSAI proposed in the usual healthcare pathway of each PD patients included
Locations (10)
Chu de Lyon
Bron, France
Hopital Gabriel Montpied
Clermont-Ferrand, France
Chu de Grenoble
Grenoble, France
Chu Limoges
Limoges, France
Chu de Nancy
Nancy, France
Chu de Nice
Nice, France
Chu de Poitiers
Poitiers, France
Chu de Rennes
Rennes, France
Chu de Rouen
Rouen, France
Chu de Toulouse
Toulouse, France